CORRECTED: Pfizer Takes Fight Over $142M Neurontin Verdict To 1st Circ.
Pfizer Inc. is challenging a $142 million jury award for HMO operator Kaiser Foundation Health Plan Inc. in multidistrict litigation over off-label marketing of pain drug Neurontin, telling the First Circuit...To view the full article, register now.
Already a subscriber? Click here to view full article